Scientists at Stanford Medicine conducted a study describing a new category of depression—labeled the cognitive biotype—which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.
Scientists at Stanford Medicine conducted a study describing a new category of depression—labeled the cognitive biotype—which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.
Leave A Comment